Rad Chat Live at UKIO Conference 2025 #24: Maryam Akhtarini - Hypoxia Challenge

Trigger Warning: cancer treatment, cancer and side effects.Bonus Episode: Rad Chat Live at UKIO Conference 2025 with Maryam Akhtarini.Stay ahead in radiotherapy and oncology by liking, following, and subscribing to Rad Chat wherever you get your podcasts.Join our supportive community of professionals who truly get it. Follow us @Rad__Chat and visit our website at www.radchat.co.uk. Together, we’re pushing boundaries in cancer care.Maryam’s links:FDA Approval of Histotripsy for Liver Tumors (Oct 2023) https://www.fda.gov/news-events/press-announcements/fda-roundup-october-13-2023 https://www.fusfoundation.org/posts/fda-approves-histotripsy-for-liver-tumors/UK Early Market Access via IDAP (May 2025)https://www.businesswire.com/news/home/20250529975697/en/HistoSonics-Edison-Histotripsy-System-Gains-Great-Britain-Early-Market-Access-Under-Unmet-Clinical-Needs-AuthorisationHOPE4LIVER Trial Results (April 2025) https://www.businesswire.com/news/home/20250428931117/en/HistoSonics-Histotripsy-System-Demonstrates-90-Local-Tumor-Control-at-12-Months-in-HOPE4LIVER-Trialshttps://www.fusfoundation.org/posts/histotripsy-for-liver-tumors-one-year-data-suggest-90-tumor-control/Histotripsy Overview (Non-Thermal Ultrasound) https://ammf.org.uk/2025/05/30/histotripsy-and-cholangiocarcinoma/NanOx and Tumour Hypoxia – Cancer Letters (Dec 2024)https://pubmed.ncbi.nlm.nih.gov/39716484/https://www.researchgate.net/publication/387307211_Enhancing_cancer_radiotherapy_efficacy_using_NanOx_a_novel_oxygenating_perfluorocarbon_nanoemulsion_that_reverses_tumour_hypoxiahttps://www.sciencedirect.com/science/article/abs/pii/S0304383524008012Rad Chat Links:Rad Chat WebsiteLink TreeFacebookInstagramLinkedInTikTokBlueSkyYouTube© Rad Chat 2025. All rights reserved.  We (or our licensors) own all intellectual property rights in this podcast and all related content, online and offline.  You may not use, copy, modify, download, archive, reproduce, distribute, display, publish, licence, create derivative works from or commercially exploit any part of our content unless we expressly agree in writing.  You must not use any images, audio, video, graphics or clips separately from their accompanying context.  Please acknowledge Rad Chat (and any identified contributors) clearly whenever referencing or sharing our content.